Advancements in Myeloma | What progress towards a cure and prevention has been made?

(4:21)

5 Multiple Myeloma Research Highlights: 2024 International Myeloma Society Meeting | For Patients

(4:15)

Top 5 Multiple Myeloma Research Breakthroughs from ASH 2024: What Patients and Families Need to Know

(5:16)

How can myeloma patients protect themselves from infections?

(4:20)

What is high-risk smoldering myeloma? Criteria, risks, and ongoing research

(4:47)

Safe Exercise Tips for Multiple Myeloma Patients | Myeloma in a Minute or Less

(1:39)

The International Myeloma Foundation's (IMF) Impact in 2022 and the Future of the IMF

(5:)

How does a myeloma patient’s lifestyle impact overall health?

(3:41)

Latest Myeloma Updates from ASH 2024: Easy-to-Understand Insights for Patients and Care Partners

(1:36:31)

What are the frontline myeloma treatment options?

(3:14)

International Myeloma Working Group (IMWG): Advancing Myeloma Research Through Global Collaboration

(3:51)

What is MGUS?

(2:59)

Frontline Therapy Advances for Multiple Myeloma Patients | ASH 2024 Insights for Patients

(3:8)

What is the latest from the International Myeloma Foundation’s Black Swan Research Initiative?

(4:16)

What are the immediate and long-term side effects of an autologous stem cell transplant (ASCT)?

(3:47)

What a Newly Diagnosed Patient Needs to Know

(36:40)

What does it mean to be refractory to Revlimid®? What other treatment options are available?

(3:30)

International Myeloma Foundation Virtual Regional Community Workshop (RCW) - Eastern Midwest

(1:56:13)

How long do I have to live with Myeloma? in a Minute or Less | Life with Multiple Myeloma

(1:27)